Chronic imatinib (> 3 years) therapy after complete resection of primary, high-risk gastrointestinal stromal tumor (GIST) is associated with low recurrence Meeting Abstract
| Authors: | Cavnar, M. J.; Balachandran, V. P.; Chi, P.; Keohan, M. L.; Tap, W. D.; DeMatteo, R. P. |
| Abstract Title: | Chronic imatinib (> 3 years) therapy after complete resection of primary, high-risk gastrointestinal stromal tumor (GIST) is associated with low recurrence |
| Meeting Title: | 102nd Annual Clinical Congress of the American College of Surgeons (ACS)/2nd Owen H Wangensteen Scientific Forum |
| Journal Title: | Journal of the American College of Surgeons |
| Volume: | 223 |
| Issue: | 4 Suppl. 2 |
| Meeting Dates: | 2016 Oct 16-20 |
| Meeting Location: | Washington, DC |
| ISSN: | 1072-7515 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2016-10-01 |
| Start Page: | e44 |
| Language: | English |
| ACCESSION: | WOS:000395825100094 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jamcollsurg.2016.08.544 |
| Notes: | Meeting Abstract -- Clinical Congress and Scientific Forum of the American-College-of-Surgeons -- OCT 16-20, 2016 -- Washington, DC -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
